National Vision Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for National Vision Holdings Inc in the second quarter 2026?
National Vision Holdings Inc achieved a return on average equity (ROE) of 5.71 % in its second quarter 2026, this is above EYE's average return on equity of 2.91%.
National Vision Holdings Inc shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $881 million

While the company's net income was fading, National Vision Holdings Inc was able to improve its ROE compared to the first quarter 2026.

Within the Medical Equipment & Supplies industry 50 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1780 to 1950.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jul 04 2026) II. Quarter	(Apr 04 2026) I. Quarter	(Jan 03 2026) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Equity Change	5.46 %	7.4 %	6.52 %	2.23 %	-
Y / Y Net Income Change	42.3 %	119.8 %	-	-	-
Net Income (TTM) in Millions	50	47	30	-2	-14
Return On Equity (TTM)	5.71 %	5.36 %	3.47 %	-0.27 %	-1.69 %
EYE's Total Ranking	# 1950	# 1780	# 1575	# 1985	# 2038
Equity (TTM) in Millions	897	898	870	859	851
Seq. Equity Change	-0.11 %	3.27 %	1.25 %	0.96 %	1.72 %
Seq. Net Income Change	-60.18 %	840.04 %	-1.63 %	-61.35 %	-38.5 %

Back to EYE Management Effectiveness >> EYE's 5 Years Annual ROE >> Compare EYE ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 51
Sector	# 164
Overall	# 1950

Return On Equity Statistics
High	Average	Low
16.89 %	2.91 %	-9.69 %
(Oct 02 2021)		(Jun 29 2024)

EYE Annual Return On Equity	(Jan 03 2026) 2025	(Dec 28 2024) 2024	(Dec 30 2023) 2023	(Dec 31 2022) 2022	(Jan 01 2022) 2021
Total Equity in Millions	870	816	829	901	926
Y / Y Equity Change	6.52 %	-1.58 %	-7.96 %	-2.69 %	2.15 %
Net Income in Millions	30	-28	-66	42	128
Y / Y Net Income Change	-	-	-	-67.15 %	253.51 %
Return On Equity	3.4 %	-3.49 %	-7.95 %	4.67 %	13.85 %

Back to EYE Management Effectiveness >> EYE's 5 Years Annual ROE >> Compare EYE ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 3.4 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
EYE's' Return on Equity at Yahoo Finance
EYE's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for EYE's Competitors
Subscribers only: Roe for National Vision Holdings Inc 's Suppliers
Subscribers only: Return On Equity for EYE's Customers

Companies with similar Return On Equity at Jul 04 2026, within Healthcare Sector	ROE
Alpha Pro Tech Ltd	15.43 %
Livanova Plc	15.41 %
Biolife Solutions Inc	15.28 %
Lifevantage Corp	15.06 %
Quest Diagnostics Inc	14.85 %
Infusystem Holdings Inc	14.81 %
Boston Scientific Corporation	14.77 %
Strata Critical Medical Inc	14.27 %
Beone Medicines Ltd	14.24 %
Royalty Pharma Plc	13.82 %
Regeneron Pharmaceuticals Inc	13.81 %
National Healthcare Corp	13.11 %
Kewaunee Scientific Corporation	12.61 %
Protagonist Therapeutics inc	11.80 %
Entrada Therapeutics Inc	11.77 %
Haemonetics Corporation	11.66 %
Globus Medical Inc	11.59 %
Labcorp Holdings Inc	11.58 %
Tactile Systems Technology Inc	11.49 %
Nature s Sunshine Products inc	11.26 %
Penumbra Inc	11.09 %
Henry Schein Inc	10.88 %
Cadre Holdings inc	10.76 %
Medtronic Plc	10.64 %
Viemed Healthcare Inc	10.53 %
U S Physical Therapy Inc	10.50 %
The Pennant Group Inc	10.18 %
Amphastar Pharmaceuticals Inc	10.11 %
Align Technology inc	10.09 %
Ardent Health Inc	9.92 %

Date modified: 2026-09-08T17:40:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.